Your browser doesn't support javascript.
loading
Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso.
Biatougou, Nakougou Moϊ-Bohm; Ouedraogo, Muriel S; Soubeiga, Serge Theophile; Zohoncon, Theodora Mahoukede; Ouedraogo, Paul; Obiri-Yeboah, Dorcas; Tapsoba, Aziz Sidi Aristide; Kiendrebeogo, Touwendpoulimdé Isabelle; Sagna, Tani; Niamba, Pascal; Traore, Adama; Simpore, Jacques.
Afiliación
  • Biatougou NM; Biochemistry and Microbiology Department, Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
  • Ouedraogo MS; Department of Dermatology, Yalgado Ouedraogo Hospital University Centre, Ouagadougou, Burkina Faso.
  • Soubeiga ST; Department of Biomedical Research, Biomolecular Research Centre Pietro Annigoni (CERBA), Ouagadougou, Burkina Faso.
  • Zohoncon TM; Department of Biomedical and Public Health, Research Institute of Health Sciences (IRSS), Ouagadougou, Burkina Faso.
  • Ouedraogo P; Biochemistry and Microbiology Department, Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
  • Obiri-Yeboah D; Department of Medicine, Saint Thomas d'Aquin University (USTA), Ouagadougou, Burkina Faso.
  • Tapsoba ASA; Department of Medicine, Saint Thomas d'Aquin University (USTA), Ouagadougou, Burkina Faso.
  • Kiendrebeogo TI; Department of Microbiology and Immunology, University of Cape Coast, Cape Coast, Ghana.
  • Sagna T; Biochemistry and Microbiology Department, Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
  • Niamba P; Biochemistry and Microbiology Department, Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.
  • Traore A; Department of Biomedical Research, Biomolecular Research Centre Pietro Annigoni (CERBA), Ouagadougou, Burkina Faso.
  • Simpore J; Department of Biomedical and Public Health, Research Institute of Health Sciences (IRSS), Ouagadougou, Burkina Faso.
HIV AIDS (Auckl) ; 14: 311-317, 2022.
Article en En | MEDLINE | ID: mdl-35836752
ABSTRACT

Introduction:

Human herpesvirus type 8 (HHV-8) is the main etiological agent of Kaposi's sarcoma. This virus is frequently associated with immunocompromision. This study aimed to detect HHV-8 in people with compromised immune system. Patients and

Methods:

This is a cross-sectional study that included 180

subjects:

179 HIV-infected patients and 1 patient with bullous pemphigoid. Blood samples were taken from all subjects, and swabs of lesions were then taken from individuals with symptoms of Kaposi's sarcoma. Viral load and CD4+ T lymphocytes count were performed for persons living with HIV and real-time PCR detection of HHV-8 DNA was performed in all subjects in the study.

Results:

Among HIV-infected persons, 13.41% had a viral load of more than 10,000 copies/mL, and 22.91% had a CD4+ T lymphocytes count of fewer than 350 cells/µL. A total of four (three HIV-1 infected patients and one patient with bullous pemphigoid) patients (2.22%) had apparent lesions of Kaposi's sarcoma. In the plasmas and swabs from associated lesions, HHV-8 DNA was found in only two individuals, with an HHV-8 prevalence of 1.11% (2/180) with 0.55% (1/179) in an HIV-infected patient on antiretroviral therapy.

Conclusion:

These results exposing low prevalence levels of HHV-8 in HIV-infected patients could be due to the beneficial effect of antiretroviral drugs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: HIV AIDS (Auckl) Año: 2022 Tipo del documento: Article País de afiliación: Burquina Faso

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: HIV AIDS (Auckl) Año: 2022 Tipo del documento: Article País de afiliación: Burquina Faso